Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
May. 09 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
May. 01 | Stifel Initiates Cullinan Oncology With Buy Rating, $40 Price Target | MT |
End-of-day quotes
Sector Other Precious Metals & Minerals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
4M | - | - | - | - | - | |
4.84B | ||||||
1.61B | - | - | ||||
1.27B | - | - | ||||
881M | - | - | - | - | - | |
911M | - | - |